What is Aardvark Therapeutics, Inc. Common Stock's Market Cap?

Aardvark Therapeutics, Inc. Common Stock's Market Cap is $107.7M, based on as-reported figures from SEC (XBRL) filings.

What is Aardvark Therapeutics, Inc. Common Stock's Enterprise Value?

Aardvark Therapeutics, Inc. Common Stock's Enterprise Value is $33.8M, based on as-reported figures from SEC (XBRL) filings.

What is Aardvark Therapeutics, Inc. Common Stock's EV / EBITDA?

Aardvark Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Aardvark Therapeutics, Inc. Common Stock's Revenue (TTM)?

Aardvark Therapeutics, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.

What is Aardvark Therapeutics, Inc. Common Stock's Net Income (TTM)?

Aardvark Therapeutics, Inc. Common Stock's Net Income (TTM) is -$69.9M, based on as-reported figures from SEC (XBRL) filings.

What is Aardvark Therapeutics, Inc. Common Stock's EBITDA?

Aardvark Therapeutics, Inc. Common Stock's EBITDA is -$73.9M, based on as-reported figures from SEC (XBRL) filings.

What is Aardvark Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Aardvark Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -3.19, based on as-reported figures from SEC (XBRL) filings.

What is Aardvark Therapeutics, Inc. Common Stock's Net Debt?

Aardvark Therapeutics, Inc. Common Stock's Net Debt is -$73.9M, based on as-reported figures from SEC (XBRL) filings.

Aardvark Therapeutics, Inc. Common Stock (AARD) Financial Statements

Aardvark Therapeutics, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG01223DLC1

XNAS · usd

4.92▼ 0.41 (-7.69%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close5.33

Day's Range4.90 – 5.46

52-Week Range3.35 – 17.94

Volume75.0K

Avg Volume128.3K

Share Statistics

Shares Outstanding

Employees40

ExchangeXNAS

Listed2025-02-13

Share count as of July 31, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Aardvark Therapeutics, Inc. Common Stock (AARD)

What is Aardvark Therapeutics, Inc. Common Stock's Market Cap?: Aardvark Therapeutics, Inc. Common Stock's Market Cap is $107.7M, based on as-reported figures from SEC (XBRL) filings.
What is Aardvark Therapeutics, Inc. Common Stock's Enterprise Value?: Aardvark Therapeutics, Inc. Common Stock's Enterprise Value is $33.8M, based on as-reported figures from SEC (XBRL) filings.
What is Aardvark Therapeutics, Inc. Common Stock's EV / EBITDA?: Aardvark Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Aardvark Therapeutics, Inc. Common Stock's Revenue (TTM)?: Aardvark Therapeutics, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is Aardvark Therapeutics, Inc. Common Stock's Net Income (TTM)?: Aardvark Therapeutics, Inc. Common Stock's Net Income (TTM) is -$69.9M, based on as-reported figures from SEC (XBRL) filings.
What is Aardvark Therapeutics, Inc. Common Stock's EBITDA?: Aardvark Therapeutics, Inc. Common Stock's EBITDA is -$73.9M, based on as-reported figures from SEC (XBRL) filings.
What is Aardvark Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Aardvark Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -3.19, based on as-reported figures from SEC (XBRL) filings.
What is Aardvark Therapeutics, Inc. Common Stock's Net Debt?: Aardvark Therapeutics, Inc. Common Stock's Net Debt is -$73.9M, based on as-reported figures from SEC (XBRL) filings.